Hee Jung Jeon

Hee Jung Jeon

Auto-generated profile, based on publicly available information

Hee Jung Jeon

Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2012 in Critical Care
Verified
Journal Article
Open access
PDF file
JAJung Nam An
Jung Nam An
JLJung Pyo Lee
Jung Pyo Lee
HJHee Jung Jeon
Hee Jung Jeon
DKDo Hyoung Kim
Do Hyoung Kim
YOYun Kyu Oh
Yun Kyu Oh
CLChun Soo Lim
Chun Soo Lim
Introduction: Severe hyperkalemia, with potassium (K+) levels ≥ 6.5 mEq/L, is a potentially life-threatening electrolyte imbalance. For prompt and effective treatment, it is important to know its risk factors, clinical manifestations, and predictors of mortality. Methods: An observational cohort study was performed at 2 medical centers. A total of 923 consecutive Korean patients were analyzed. All were 19 years of age or older and were hospitalized with severe hyperkalemia between August 2007 and July 2010; the diagnosis of severe hyperkalemia was made either at the time of admission to the hospital or during the period of hospitalization. Demographic and baseline clinical characteristics at the time of hyperkalemia diagnosis were assessed, and clinical outcomes such as in-hospital mortality were reviewed, using the institutions' electronic medical record systems. Results: Chronic kidney disease (CKD) was the most common underlying medical condition, and the most common precipitating factor of hyperkalemia was metabolic acidosis. Emergent admission was indicated in 68.6% of patients, 36.7% had electrocardiogram findings typical of hyperkalemia, 24.5% had multi-organ failure (MOF) at the time of hyperkalemia diagnosis, and 20.3% were diagnosed with severe hyperkalemia at the time of cardiac arrest. The in-hospital mortality rate was 30.7%; the rate was strongly correlated with the difference between serum K+ levels at admission and at their highest point, and with severe medical conditions such as malignancy, infection, and bleeding. Furthermore, a higher in-hospital mortality rate was significantly associated with the presence of cardiac arrest and/or MOF at the time of diagnosis, emergent admission, and intensive care unit treatment during hospitalization. More importantly, acute kidney injury (AKI) in patients with normal baseline renal function was a strong predictor of mortality, compared with AKI superimposed on CKD. Conclusions: Severe hyperkalemia occurs in various medical conditions; the precipitating factors are similarly diverse. The mortality rate is especially high in patients with severe underlying disease, coexisting medical conditions, and those with normal baseline renal function.

29 September 2012 in Transplant International
Verified
Journal Article
Open access
PDF file
HJHee Jung Jeon
Hee Jung Jeon
YKYoon Jung Kim
Yoon Jung Kim
HKHyuk Yong Kwon
Hyuk Yong Kwon
TKTai Yeon Koo
Tai Yeon Koo
SBSeon Ha Baek
Seon Ha Baek
JYJaeseok Yang
Jaeseok Yang
We performed retrospective, multi‐center study of the impacts of parathyroidectomy (PTX) after or before kidney transplantation on allograft outcomes. A total of 63 patients who underwent PTX after kidney transplantation were identified. Deterioration in eGFR by more than 25% at 1 month after PTX occurred in 20% of the patients. The baseline eGFR was significantly lower in impairment group than nonimpairment group [adjusted odds ratio (OR) 0.87, 95% confidence interval (CI) 0.77–0.99, P = 0.033]. Low iPTH concentration after PTX was also a significant risk factor for the renal impairment (OR 0.96, CI 0.94–0.99, P = 0.009). A total of 37 patients who underwent PTX before transplantation were identified. Thirty‐six percent of the patients had persistent hyperparathyroidism by 1 year after transplantation. A high iPTH level before PTX was a significant risk factor for persistent post‐transplant hyperparathyroidism (adjusted OR 1.002, CI 1.000–1.005, P = 0.039). Finally, eGFR values during the first 5 years after transplantation were significantly lower in the patients who underwent PTX at less than 1 year after transplantation, than the pretransplant PTX patients (P = 0.032). As PTX after kidney transplantation has a risk of deterioration of allograft function, pretransplant PTX should be considered for patients with severe hyperparathyroidism, who could undergo post‐transplant PTX.

21 April 2014 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
HJH.J. Jeon
H.J. Jeon
HRH. Ro
H. Ro
JJJong Cheol Jeong
Jong Cheol Jeong
TKT.Y. Koo
T.Y. Koo
MHM. Han
M. Han
JYJ. Yang
J. Yang

8 February 2014 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MHMiyeun Han
Miyeun Han
JJJong Cheol Jeong
Jong Cheol Jeong
TKTai Yeon Koo
Tai Yeon Koo
HJHee Jung Jeon
Hee Jung Jeon
HKHyuk Yong Kwon
Hyuk Yong Kwon
JYJaeseok Yang
Jaeseok Yang

28 July 2022 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
HJHee Jung Jeon
Hee Jung Jeon
TKTai Yeon Koo
Tai Yeon Koo
MJMan Ki Ju
Man Ki Ju
DCDong-Wan Chae
Dong-Wan Chae
SCSoo Jin Na Choi
Soo Jin Na Choi
JYJaeseok Yang
Jaeseok Yang
Background: As the need for a nationwide organ-transplant registry emerged, a prospective registry, the Korean Organ Transplantation Registry (KOTRY), was initiated in 2014. Here, we present baseline characteristics and outcomes of the kidney-transplant cohort for 2014 through 2019. Methods: The KOTRY consists of five organ-transplant cohorts (kidney, liver, lung, heart, and pancreas). Data and samples were prospectively collected from transplant recipients and donors at baseline and follow-up visits; and epidemiological trends, allograft outcomes, and patient outcomes, such as posttransplant complications, comorbidities, and mortality, were analyzed. Results: From 2014 to 2019, there were a total of 6,129 registered kidney transplants (64.8% with living donors and 35.2% with deceased donors) with a mean recipient age of 49.4 ± 11.5 years, and 59.7% were male. ABO-incompatible transplants totaled 17.4% of all transplants, and 15.0% of transplants were preemptive. The overall 1- and 5-year patient survival rates were 98.4% and 95.8%, respectively, and the 1- and 5-year graft survival rates were 97.1% and 90.5%, respectively. During a mean follow-up of 3.8 years, biopsy- proven acute rejection episodes occurred in 17.0% of cases. The mean age of donors was 47.3 ± 12.9 years, and 52.6% were male. Among living donors, the largest category of donors was spouses, while, among deceased donors, 31.2% were expanded-criteria donors. The mean serum creatinine concentrations of living donors were 0.78 ± 0.62 mg/dL and 1.09 ± 0.24 mg/dL at baseline and 1 year after kidney transplantation, respectively. Conclusion: The KOTRY, a systematic Korean transplant cohort, can serve as a valuable epidemiological database of Korean kidney transplants.

26 November 2013 in Nephrology
Verified
Journal Article
Closed access
PDF file
MKMyung‐Gyu Kim
Myung‐Gyu Kim
YKYoon Jung Kim
Yoon Jung Kim
HKHyuk Yong Kwon
Hyuk Yong Kwon
HPHayne Cho Park
Hayne Cho Park
TKTai Yeon Koo
Tai Yeon Koo
JYJaeseok Yang
Jaeseok Yang